Skip to content
VICNetwork Webinar: HPV Vaccine is Cancer Prevention... So what's the hold up? - Jan 28, 2014
*
1.
Please share the name of your organization.
(Required.)
*
2.
Which of the following best describes you?
(Required.)
Physician
Pharmacist
Nurse
Other health care provider
Public Information Officer/Risk Communicator
Health care administrator
Health Educator
Researcher
Other, please specify
*
3.
Please select the state (or territory) where your organization is based.
(Required.)
Alabama
Alaska
American Samoa
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Guam
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Northern Marianas Islands
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Virgin Islands
Washington
West Virginia
Wisconsin
Wyoming
Other / non-US
Other / non-US (please specify)
*
4.
How did you hear about this webinar?
(Required.)
E-mail forwarded by colleague
E-mail from VICNetwork
NPHIC or CIC website
Social Media site (Twitter, Facebook)
Newsletter
Other (please specify)
*
5.
Did the Webinar meet the following objective? (If you feel the objective was partially met or not met, please comment.)
Describe the burden of HPV infection and related disease
(Required.)
Yes
Somewhat
No
Not Sure
Comment
*
6.
Did the Webinar meet the following objective? (If you feel the objective was partially met or not met, please comment.)
Provide information about HPV vaccination, including recommendations, safety, and impact
(Required.)
Yes
Somewhat
No
Not Sure
Comment
*
7.
Did the Webinar meet the following objective? (If you feel the objective was partially met or not met, please comment.)
Share and employ best practices for HPV vaccine communication and strong recommendations
(Required.)
Yes
Somewhat
No
Not Sure
Comment
*
8.
Did the Webinar meet the following objective? (If you feel the objective was partially met or not met, please comment.)
Utilize CDC's HPV vaccine communication products and messages
(Required.)
Yes
Somewhat
No
Not Sure
Comment
*
9.
Please rate the relevance of this information to your work/professional development:
(Required.)
Excellent
Good
Fair
Poor
Excellent
Good
Fair
Poor
*
10.
Please rate the overall quality of the presentation given by
Anne Schuchat, M.D.
(Required.)
Excellent
Good
Fair
Poor
Excellent
Good
Fair
Poor
*
11.
Please rate the overall quality of the presentation given by
Jill B. Roark, MPH
(Required.)
Excellent
Good
Fair
Poor
Excellent
Good
Fair
Poor
*
12.
Overall quality of the session
(Required.)
Excellent
Good
Fair
Poor
Excellent
Good
Fair
Poor
*
13.
What do feel is the biggest barrier to improving HPV vaccination rates?
(Required.)
*
14.
What type of training or education would help you feel more comfortable recommending this vaccine to adolescents and their parents?
(Required.)
*
15.
Do you routinely recommend HPV vaccine to 11-12 year old
female
patients?
(Required.)
Yes
No
N/A
Other (please specify)
*
16.
Do you routinely recommend HPV vaccine to 11-12 year old
male
patients?
(Required.)
Yes
No
N/A
Other (please specify)
*
17.
Were you able to access the presentation on-line through WebEx? If not, please describe any technical issues encountered.
(Required.)
Yes
No
Comment
*
18.
How many persons listened to the Webinar at your site?
(Required.)
19.
What is the most important thing or idea you learned from this webinar?
20.
How might you incorporate this new information into your organization?
21.
Please share other feedback or suggestions on the session.
